What is a Certificate of Analysis (COA) and what should it contain?

A COA is a document from a testing laboratory that verifies a product's identity, purity, and composition. A legitimate COA should include: (1) the testing laboratory's name and accreditation, (2) a unique report number and date, (3) the product name and batch/lot number matching the product, (4) quantitative purity results (typically HPLC — High Performance Liquid Chromatography), (5) identity confirmation (mass spectrometry), (6) testing for contaminants (heavy metals, endotoxins, sterility), and (7) the analyst's signature. A COA without a batch number, without quantitative results, or from an unaccredited lab is not reliable. Always verify the COA directly with the testing laboratory — do not trust a PDF alone.

How do I verify a compounding pharmacy is legitimate?

Legitimate compounding pharmacies in the US must be licensed by their state board of pharmacy. You can verify a pharmacy's license through your state's board of pharmacy website (search '[state name] board of pharmacy license lookup'). FDA-registered 503B outsourcing facilities must also register with the FDA and are listed in the FDA's public database. A legitimate compounding pharmacy will: have a physical address (not a PO box), display their state license number publicly, require a valid prescription, and have a pharmacist available for consultation. Be extremely cautious of any entity selling prescription peptides without requiring a prescription — this is illegal under federal law.

What is the FDA Category 2 list and which peptides are affected?

The FDA maintains lists of bulk drug substances that may or may not be used in compounding. Category 2 substances are those that have been nominated but NOT placed on the allowed list — meaning compounding pharmacies cannot legally use them. In 2024, the FDA added several peptides to Category 2, including BPC-157, certain GHRPs (growth hormone releasing peptides), and other research peptides that lacked sufficient safety data for human compounding. This means these peptides cannot be legally compounded by 503A or 503B pharmacies in the US. The Category 2 list is published and updated on the FDA website: fda.gov/compounding.

What's the difference between a compounding pharmacy and a research chemical seller?

Compounding pharmacies (503A or 503B) are FDA-regulated facilities that prepare customized medications for individual patients with a valid prescription. They must follow USP compounding standards, are inspected by state boards and/or FDA, and can only compound from FDA-allowed substances. Research chemical sellers are unregulated entities that sell peptides 'for research purposes only' or 'not for human consumption.' They are not licensed pharmacies, are not inspected for sterility or quality, and operate in a legal gray area. Products from research chemical sellers have no quality assurance, may be mislabeled or contaminated, and are illegal for human use. The distinction is not just about quality — it's about legality.

How can I safely get peptides through a healthcare provider?

The legitimate pathway for obtaining peptide therapies in the US is: (1) consult with a licensed healthcare provider (MD, DO, NP, PA), (2) receive a medical evaluation and diagnosis, (3) if appropriate, receive a valid prescription, (4) fill the prescription at a licensed pharmacy (retail or compounding). Telehealth providers can prescribe when they are licensed in your state and conduct appropriate clinical evaluations. Verify any telehealth provider's license through your state medical board website. Be wary of any service that prescribes without a medical evaluation, offers peptides without a prescription, or markets 'research chemicals' for human use.

Important Safety Notice

This guide provides educational safety information only. It does NOT recommend or endorse any specific peptide sources, sellers, or vendors. Our goal is to teach you how to evaluate quality and identify red flags, not where to buy. Purchasing unregulated peptides carries significant health and legal risks. Always consult a licensed healthcare provider. PeptideScholar does not facilitate, profit from, or endorse the sale of unapproved peptides.

How to Evaluate Peptide Sources Safely

This is not a source list. This is a guide to developing the skills to verify quality, identify scams, and understand the legal landscape — so you can protect yourself.

Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.

Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.

No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.

The Legal Landscape: Know What You're Dealing With

There are fundamentally two legal categories for obtaining peptides in the United States. Understanding this distinction is essential for your safety.

✓ Legitimate Pathway

• Licensed healthcare provider evaluation
• Valid prescription issued
• Dispensed by licensed pharmacy (retail or compounding)
• FDA-regulated supply chain
• USP compounding standards (503A/503B)
• State board of pharmacy oversight
• Batch-specific quality testing
• Sterility and purity verified

✗ Risk Pathway

• No prescription or medical evaluation
• 'Research chemical' or 'not for human use' labeling
• Unlicensed seller — no pharmacy license
• No FDA oversight or inspection
• No sterility standards enforced
• Unverifiable or fake COAs
• Unknown purity, contaminants, or identity
• Potential legal liability for buyer

FDA Category 2: In 2024, the FDA placed several popular peptides on the Category 2 list of bulk drug substances that cannot be used in compounding. This includes BPC-157 and certain growth hormone releasing peptides (GHRPs). These peptides cannot be legally compounded by any US pharmacy — 503A or 503B. Any seller offering compounded BPC-157 or Category 2 peptides is operating outside FDA regulations. FDA Compounding Resources →

How to Read a Certificate of Analysis (COA)

A COA is the primary quality document for peptides. Here's what a legitimate one contains — and how to spot a fake.

What a legitimate COA must include:

!Testing laboratory name + accreditation

!Unique report number + date of testing

!Batch/lot number — must match product

!Quantitative purity result (e.g., 99.2% by HPLC)

•Identity confirmation (mass spectrometry)

•Heavy metals testing (lead, mercury, arsenic)

•Endotoxin testing (EU/mg)

•Sterility testing (USP <71>)

•Residual solvents testing

•Analyst signature and review date

How to verify a COA is real: Do not trust a PDF alone. Contact the testing laboratory directly using their publicly listed contact information (not contact info provided by the seller). Provide the report number and batch number and ask them to confirm the results. Reputable third-party testing laboratories will verify their reports.

Red flags on COAs: Missing batch/lot number, no quantitative purity data (just 'pass/fail'), the testing lab doesn't exist or has no web presence, the COA is from a lab that doesn't actually test peptides, or the seller refuses to provide batch-specific COAs and only shows a 'representative' one.

Tools: Use our COA Verifier Tool to walk through a systematic verification checklist.

Red Flags: How to Spot a Problematic Seller

These patterns should make you stop and reconsider. They are not exhaustive — use your judgment.

Critical

No prescription required

Any seller offering prescription peptides (semaglutide, tirzepatide, etc.) without requiring a prescription is operating illegally. FDA-approved peptides require a prescription by law. This is the single most important red flag.

Critical

Vague about sourcing or testing

Legitimate pharmacies and manufacturers are transparent about their quality control. If a seller cannot provide batch-specific COAs from accredited third-party labs, or is evasive about their supply chain, do not trust their products.

High

Prices far below market

FDA-approved GLP-1 agonists have known price ranges (Wegovy ~$1,300/month cash price, compounded versions $200-500/month). Significantly lower prices suggest counterfeit, diluted, or mislabeled products. If it seems too good to be true, it is.

High

Marketing 'research chemicals' for human use

Products labeled 'for research purposes only' or 'not for human consumption' that are clearly marketed for human use are operating in a legal gray area at best, illegally at worst. These products have no quality control, no sterility testing, and no regulatory oversight.

High

No physical address or verifiable license

Legitimate pharmacies have a physical address and verifiable state license. Be wary of sellers with only a PO box, no address at all, or a license number that cannot be verified through the state board of pharmacy website.

Medium

Aggressive marketing or urgency tactics

Limited-time offers, countdown timers, 'while supplies last,' and high-pressure sales tactics are inconsistent with legitimate healthcare. Licensed pharmacies do not market this way. These tactics are common among scam sellers.

Critical

Fake or recycled COAs

Some sellers provide fraudulent COAs — either completely fabricated, recycled from old batches, or from unaccredited labs. Always verify a COA by contacting the testing laboratory directly using the lab's publicly listed contact information (not contact info provided by the seller). A COA from 'Janoshik' or 'MZ Biolabs' should be verifiable through those labs' websites.

The Legitimate Pathway: Telehealth Prescribing

If you're interested in FDA-approved peptide therapies (GLP-1 agonists like semaglutide and tirzepatide), the legitimate pathway is through a licensed healthcare provider. Here's how to verify a provider is legitimate:

Verify the provider's medical license through your state medical board website. Every state has an online license lookup.

Search '[state name] medical board license lookup' — it takes 30 seconds.

Confirm the provider conducts a real medical evaluation — not just a 2-minute questionnaire.

A legitimate telehealth visit includes medical history review, current medications, allergies, and appropriate lab work or prior records.

Verify the pharmacy filling your prescription is licensed by your state board of pharmacy.

Search '[state name] board of pharmacy license lookup' and confirm the pharmacy's license is active and in good standing.

Be extremely cautious of any provider that prescribes without an evaluation, or any pharmacy that ships without a prescription.

This is illegal under federal and state law.

Peptide Sourcing Safety: FAQ

Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.

Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.

No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.

Get the Peptide Safety Checklist

Free PDF: COA verification checklist, red flags reference card, and telehealth provider verification guide.

Free DownloadPeptide Safety ChecklistCOA verification walkthrough, 10 red flags to watch for, and step-by-step telehealth provider verification — keep it handy.PDF

No spam. Unsubscribe anytime.